@thepatientinvestorr
YouTube
Avg. Quality
69
Success Rate
24.11
Analysis
224
Correct
54
Fail
118
Pending
52
Ineffective
0
Total Quality
Score
If You Had Traded on This Analysis…
Fail
HIMS
Long Entry
48.1800
2025-09-04
20:59 UTC
Target
67.4200
Fail
40.0000
In 2 Months
Risk/Reward
1 : 2
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
Final PnL
-16.98%
P/L: —
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
The analysis focuses on Hims & Hers Health (HIMS). The stock is currently at $44.46, down approximately 30% over the previous month but up 76% year-to-date. The presenter notes HIMS is trading at roughly three times sales with approximately 54% sales growth and 80% gross margins. A potential lawsuit and related negative media could be ending. The pundit suggests HIMS can obtain a rerating to 6-10 times sales. Expansion into Europe and Canada are also noted. The target price is inferred to be 67.42 with the failure bound set around $40.00. The prediction timeframe is approximately 5 years and the current and predicted trend is that it will become bullish soon.
